In the article “Early cervical myelitis after human papilloma virus vaccination” by M. Fernández-Fournier et al. (Neurology® Neuroimmunology & Neuroinflammation 2014;1:e31–e32), there is an error in the name of the vaccine used, which was in fact the bivalent HPV vaccine with a combined diphtheria/tetanus/pertussis vaccine rather than the quadrivalent HPV vaccine Gardasil, as reported in the article. Accordingly, the authors wish to reword several sentences in the article. Under “Case report,” the third sentence should read: “Three days earlier she had received a first dose of bivalent HPV recombinant vaccine together with a combined diphtheria/tetanus/pertussis (DTP) vaccine.” In the third paragraph of the Discussion, the first 2 sentences should read: “We present a case of transverse myelitis 3 days after HPV and DTP immunization. To our knowledge, this is the earliest case of CNS inflammation following either HPV or DTP immunization, with a less than 7-day interval from vaccination to symptom onset.” Sentence 4 should read: “DTP vaccination might have triggered demyelination; however, CNS demyelination is more frequently associated with HPV vaccination in the medical literature.4” The last sentence of the article should read: “However, we must continue to report and investigate cases of inflammatory disorders of the CNS associated with vaccination, both for safety reasons and because it may help comprehend the pathogenesis of subsequent CNS demyelination.” The authors regret the errors.
- © 2015 American Academy of Neurology
Letters: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.